Drug Profile
Research programme: antifungals - Microbia
Alternative Names: Anti-Invasins; Antifungals research programme - Microbia; MM-86553Latest Information Update: 17 Sep 2007
Price :
$50
*
At a glance
- Originator Whitehead Institute for Biomedical Research
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Aspergillosis; Candidiasis; Mycoses
Most Recent Events
- 25 Sep 2003 Data presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2003) have been added to the Antibacterials antimicrobial activity section ,
- 12 Jun 2003 Preclinical trials in Aspergillosis in USA (unspecified route)
- 12 Jun 2003 Preclinical trials in Candidiasis in USA (unspecified route)